Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BridgeBio
Pharma
FDA approves Ascendis' achondroplasia treatment Yuviwel
The FDA has approved Ascendis' Yuviwel, a once-weekly injection to treat children with achondroplasia, a rare genetic disorder that causes dwarfism.
Kevin Dunleavy
Mar 2, 2026 9:25am
BridgeBio CEO shrugs off recent Attruby pricing pressure fears
Feb 25, 2026 2:30pm
Alnylam hits profitability in Q4 despite Amvuttra revenue miss
Feb 12, 2026 11:05am
BridgeBio shares slide on Pfizer's ATTR patent withdrawal
Feb 6, 2026 10:50am
Is Pfizer's recent ATTR sales decline in the US a warning sign?
Dec 2, 2025 8:20am
BioMarin touts pipeline asset as potential Voxzogo replacement
Aug 5, 2025 11:30am
